Health-Related Quality of Life and Emerging Therapies In PBC
Автор: Chronic Liver Disease Foundation
Загружено: 2024-07-22
Просмотров: 132
Join Dr. Paul Kwo from Stanford University as he hosts a discussion with Dr. John Vierling of Baylor College of Medicine on the latest advancements in the treatment of primary biliary cholangitis (PBC). In this episode, Dr. Vierling shares insights from key clinical trials and the anticipated impact of new therapies like elianor (a PAR-alpha and delta agonist) and cadelpar (a pure PAR-delta agonist). They discuss how these emerging treatments will revolutionize management strategies, addressing both disease progression and quality of life improvements. Tune in for a deep dive into PBC management, including practical tips on monitoring and optimizing patient care with these new therapeutic options. For more information, visit our website. https://www.chronicliverdisease.org/
Don't forget to subscribe and stay updated on the latest episodes and medical insights!
#pbc #primarybiliarycholangitis #ursodiol #elafibranor #seladelpar #paragonists #cholestaticliverdisease #alkalinephosphatase #bileacidtherapy #fibrosistesting #liverhealth #pbcawareness #hepaticpruritus #liverfibrosis #ibatinhibitors #autoimmuneliverdisease #overlapsyndrome #gp210 #sp100 #hepatology #livertherapies
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
